BioPharm International-09-01-2015

BioPharm International

Manufacturers Face Key Policy and Regulatory Challenges

September 01, 2015

Regulatory Beat

28

9

Legislation to streamline drug development may get tangled up in user fee negotiations and drug pricing battles.

The Metrics of Quality Culture

September 01, 2015

Quality

28

9

FDA’s proposed guidance for quality metrics raises questions about quantifying the tangibles and intangibles of quality culture.

BioPharm International, September 2015 Issue (PDF)

September 01, 2015

Issue PDF

28

9

Click the title above to open the BioPharm International September 2015 issue in an interactive PDF format.